Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

The method effectively measures drug impact on DHT levels in prostate treatments.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Human liver enzyme DHEA ST helps process minoxidil.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Patients with acne vulgaris have lower serum irisin levels.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Finasteride may affect PNMT, causing side effects.